BridgeBio possesses a medium revenue cyclicality rating, and its operating leverage has a low rating. We assess the company's balance sheet as weak due to management's dependence on debt issuance to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback